What is the proper preparation and administration of nebulised salbutamol (albuterol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Prepare Nebulised Salbutamol

For acute asthma or COPD exacerbations, prepare nebulised salbutamol by diluting the appropriate dose (2.5-5 mg for adults, 0.15 mg/kg or 5 mg for children) in a minimum total volume of 3 mL using normal saline, and deliver via oxygen-driven nebulizer at 6-8 L/min flow rate. 1

Standard Preparation Protocol

Dosing by Patient Population

Adults:

  • Standard dose: 2.5-5 mg salbutamol nebuliser solution 1
  • Acute severe asthma: 5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed 1
  • COPD exacerbations: 2.5-5 mg every 4-6 hours for 24-48 hours or until clinically improving 1

Children:

  • Weight-based: 0.15 mg/kg (minimum 2.5 mg) 1
  • Standard pediatric dose: 5 mg every 20 minutes for 3 doses in acute severe asthma 1
  • For children under 5 years, consider starting with half doses 2

Infants:

  • 2.5 mg diluted in 2-3 mL normal saline every 20 minutes for up to 3 doses during acute bronchospasm 3

Dilution Requirements

Critical preparation steps:

  • Always dilute to a minimum total volume of 3 mL using normal saline (0.9% NaCl) 1, 2
  • Never use water as a diluent, as it can cause paradoxical bronchoconstriction in some patients, particularly infants 4
  • While one study showed water dilution may not significantly reduce bronchodilator response in adults 5, normal saline remains the standard of care to avoid hypotonic-induced bronchoconstriction 4

Nebulizer Setup and Delivery

Equipment configuration:

  • Use oxygen as the driving gas at 6-8 L/min flow rate whenever possible, especially in acute severe asthma 1
  • For COPD patients with carbon dioxide retention and acidosis, use air-driven nebulization (not high-flow oxygen) to avoid worsening hypercapnia 1
  • Large volume nebulizers should be used for continuous administration if required 1

Administration technique:

  • Ensure proper face mask fit for infants and young children who cannot use mouthpieces 3
  • For children over 4 years, a mouthpiece is preferred over face mask 1
  • Treatment typically takes 5-10 minutes to complete nebulization 1

Combination Therapy Preparation

When to add ipratropium bromide:

  • In acute severe asthma with poor initial response to salbutamol alone 1
  • Mix ipratropium bromide 250-500 μg directly with salbutamol in the same nebulizer chamber 1, 6
  • For adults: add 500 μg ipratropium to salbutamol 1
  • For children: add 250 μg ipratropium to salbutamol 1

Frequency and Monitoring

Treatment intervals:

  • Acute severe cases: every 20 minutes for first 3 doses 1
  • If improving: reduce to every 1-4 hours as needed 1
  • Chronic stable disease: typically 4-6 hourly 1

Important monitoring parameters:

  • Peak flow rate before and 30 minutes after treatment 1
  • Heart rate, respiratory rate, oxygen saturation 3
  • Watch for tachycardia, tremor, and palpitations as dose-related side effects 7

Critical Pitfalls to Avoid

Common errors in preparation:

  • Do not use undiluted salbutamol solution - always ensure minimum 3 mL total volume 1, 2
  • Do not use water as diluent - use only normal saline to prevent paradoxical bronchoconstriction 4
  • Do not use oxygen-driven nebulization in COPD patients with CO2 retention - use air-driven instead 1
  • In elderly patients, supervise first treatment as beta-agonists may rarely precipitate angina 1

Equipment maintenance:

  • Nebulizer chambers and masks must be cleaned regularly to prevent medication buildup and bacterial contamination 8
  • Ensure nebulizer is functioning properly before each use 1

Special Considerations

Dose optimization:

  • Research suggests 3 mg may be an optimal dose for adults, providing satisfactory bronchodilation with fewer systemic side effects compared to higher doses 7
  • However, current guidelines recommend 2.5-5 mg for acute exacerbations based on severity 1
  • Patients with peak flow <140 L/min gain maximum benefit from combination therapy with ipratropium 9

Alternative delivery:

  • Metered dose inhaler with spacer is equally effective as nebulizer for mild-to-moderate exacerbations when used with appropriate technique, typically requiring 1/4 of the nebulizer dose 10
  • Consider MDI with spacer (4-8 puffs every 20 minutes) as alternative if nebulizer unavailable 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Recommended Dose of Nebulised Levosalbutamol in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Salbutamol Nebulization Dosing for Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Levolin Nebulizer Solution Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the alternative to salbutamol (albuterol) for plain nebulisation in patients with respiratory conditions?
Do you need to mix saline with salbutamol (albuterol) for nebulization?
What is the recommended regimen for administering salbutamol (albuterol) and Pulmicort (budesonide) via a nebuliser?
How to manage a 65-year-old with chest infection, productive cough, SOB (shortness of breath), and wheeze, with a history of asthma, hypertension, and hyperlipidemia, on salbutamol (albuterol), Amlodipine, chlorthalidone, Flixonase (fluticasone), rosuvastatin, aspirin, montelukast, quinapril, metformin, and Relvar Ellipta (fluticasone/vilanterol)?
What is the most appropriate immediate management for a patient with COPD (Chronic Obstructive Pulmonary Disease) exacerbation due to super-added pneumonia who is becoming drowsy despite receiving IV (intravenous) fluids, antibiotics, nebulized salbutamol (albuterol) and ipratropium, and nasal oxygen?
How to correct hypophosphatemia using Glycophos (Sodium Glycerophosphate)?
What is the recommended dosage of intravenous (IV) phosphate for treating hypophosphatemia?
What is the initial treatment approach for a patient with an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) versus COPD with pneumonia?
What is the most common first-line indication for Venlafaxine (Effexor)?
What solution can be used to dilute phosphate intravenous (IV)?
What is the recommended dilution ratio of normal saline to salbutamol (albuterol) for nebulization according to age?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.